{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:08:00Z","timestamp":1788995280460,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460083"],"award-info":[{"award-number":["82460083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["MS[2025]034"],"award-info":[{"award-number":["MS[2025]034"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejps.2026.107636","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:06:01Z","timestamp":1786518361000},"page":"107636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GW0742 prevents neointima formation by upregulating FABP3 expression"],"prefix":"10.1016","volume":"226","author":[{"given":"Xuesheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Han","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107636_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2015.03.008","article-title":"Activation of PPARbeta\/delta protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen\/nitrogen species and expression of matrix metalloproteinases","volume":"95-96","author":"Barlaka","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2026.107636_bib0028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1752-8062.2009.00098.x","article-title":"Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol","volume":"2","author":"Briand","year":"2009","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejps.2026.107636_bib0029","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cellsig.2006.12.007","article-title":"Ligand activation of peroxisome proliferator-activated receptor-beta\/delta(PPARbeta\/delta) inhibits cell growth of human N\/TERT-1 keratinocytes","volume":"19","author":"Burdick","year":"2007","journal-title":"Cell Signal."},{"key":"10.1016\/j.ejps.2026.107636_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13386","article-title":"Methyltransferase-like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation","volume":"56","author":"Fang","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ejps.2026.107636_bib0026","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/JAHA.117.006377","article-title":"Ectopic fatty acid-binding protein 4 expression in the vascular endothelium is involved in neointima formation after vascular injury","volume":"6","author":"Fuseya","year":"2017","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.ejps.2026.107636_bib0027","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00011-007-7157-4","article-title":"Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta\/delta ligand GW0742","volume":"57","author":"Haskova","year":"2008","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejps.2026.107636_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13148-022-01321-8","article-title":"JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells","volume":"14","author":"He","year":"2022","journal-title":"Clin. Epigenetics."},{"key":"10.1016\/j.ejps.2026.107636_bib0017","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.3390\/ijms21124403","article-title":"Investigating the role of PPAR\u03b2\/\u03b4 in retinal vascular remodeling using Ppar\u03b2\/\u03b4-deficient mice","volume":"21","author":"Ho","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107636_bib0015","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/ATVBAHA.115.306962","article-title":"Activation of peroxisome proliferator-activated receptor-delta as novel therapeutic strategy to prevent in-stent restenosis and stent thrombosis","volume":"36","author":"Hytonen","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejps.2026.107636_bib0001","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/CIRCRESAHA.122.321005","article-title":"PHB2 Maintains the Contractile Phenotype of VSMCs by Counteracting PKM2 Splicing","volume":"131","author":"Jia","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejps.2026.107636_bib0020","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/biomedicines10092283","article-title":"The role of fatty acid binding protein 3 in cardiovascular diseases","volume":"10","author":"Li","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.ejps.2026.107636_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102778","article-title":"Mitochondria spatially and temporally modulate VSMC phenotypes via interacting with cytoskeleton in cardiovascular diseases","volume":"64","author":"Li","year":"2023","journal-title":"Redox. Biol."},{"key":"10.1016\/j.ejps.2026.107636_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108157","article-title":"Pharmacological prevention of intimal hyperplasia: a state-of-the-art review","volume":"235","author":"Melnik","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107636_bib0012","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/CS20160141","article-title":"Activation of PPARbeta\/delta prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries","volume":"130","author":"Morales-Cano","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejps.2026.107636_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2023.08.005","article-title":"PPAR\u03b4 activation improves cardiac mitochondrial homeostasis in desmin deficient mice but does not alleviate systolic dysfunction","volume":"183","author":"Palioura","year":"2023","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejps.2026.107636_bib0009","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.3390\/ijms22126399","article-title":"Cardioprotective effects of PPAR\u03b2\/\u03b4 activation against ischemia\/reperfusion injury in rat heart are associated with ALDH2 upregulation, amelioration of oxidative stress and preservation of mitochondrial energy production","volume":"22","author":"Papatheodorou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107636_bib0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.ATV.0000250972.83623.61","article-title":"Activation of PPARbeta\/delta induces endothelial cell proliferation and angiogenesis","volume":"27","author":"Piqueras","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejps.2026.107636_bib0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/antiox12030645","article-title":"Fatty acid binding proteins 3 and 4 predict both all-cause and cardiovascular mortality in subjects with chronic heart failure and type 2 diabetes mellitus","volume":"12","author":"Rodriguez-Calvo","year":"2023","journal-title":"Antioxidants. (Basel)"},{"key":"10.1016\/j.ejps.2026.107636_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107515","article-title":"PPAR\u03b2\/\u03b4 prevents inflammation and fibrosis during diabetic cardiomyopathy","volume":"210","author":"Rostami","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2026.107636_bib0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13287-022-02840-0","article-title":"PPARbeta\/delta priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury","volume":"13","author":"Sarre","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejps.2026.107636_bib0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jnr.20153","article-title":"Effect of the peroxisome proliferator-activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons","volume":"77","author":"Smith","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejps.2026.107636_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","article-title":"PPAR agonists for the treatment of neuroinflammatory diseases","volume":"45","author":"Titus","year":"2024","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2026.107636_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yexcr.2014.02.015","article-title":"Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia","volume":"323","author":"Wang","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejps.2026.107636_bib0006","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/eurheartj\/ehab140","article-title":"A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy","volume":"42","author":"Wierer","year":"2021","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.ejps.2026.107636_bib0025","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1093\/rheumatology\/keab788","article-title":"FABP3 overexpression promotes vascular fibrosis in Takayasu's arteritis by enhancing fatty acid oxidation in aorta adventitial fibroblasts","volume":"61","author":"Wu","year":"2022","journal-title":"Rheumatology. (Oxford)"},{"key":"10.1016\/j.ejps.2026.107636_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90395-0","article-title":"Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease","volume":"11","author":"Zamzam","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107636_bib0022","article-title":"Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: a three-year prospective follow-up study","volume":"55","author":"Zamzam","year":"2023","journal-title":"EClin. Med."},{"key":"10.1016\/j.ejps.2026.107636_bib0014","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cvr\/cvt152","article-title":"Effects of peroxisome proliferator-activated receptor-beta activation in endothelin-dependent hypertension","volume":"99","author":"Zarzuelo","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejps.2026.107636_bib0016","article-title":"PPAR\u03b2\/\u03b4, a Novel Regulator for Vascular Smooth Muscle Cells Phenotypic Modulation and Vascular Remodeling after Subarachnoid Hemorrhage in Rats","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107636_bib0005","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.apsb.2023.11.012","article-title":"The lysine methyltransferase SMYD2 facilitates neointimal hyperplasia by regulating the HDAC3-SRF axis","volume":"14","author":"Zhong","year":"2024","journal-title":"Acta Pharm. Sin. B"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:38:41Z","timestamp":1788993521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"alternative-id":["S0928098726002101"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107636","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GW0742 prevents neointima formation by upregulating FABP3 expression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107636"}}